The Importance of a Robust Reimbursement Strategy for European Medical Device Companies Entering the US Healthcare Market and Considerations for Opportunities in the EU Market
Developing a successful reimbursement strategy early is critical for European medical device companies to achieve market access and success in the U.S. The U.S. healthcare landscape is highly fragmented, with multiple payers and reimbursement methods, making the barrier of entry complex and challenging to navigate. European medical device companies must develop pricing strategies and gain a competitive advantage to achieve success in the U.S. healthcare market.